AMI Cardiogenic Shock

Clinical Evidence

Key Findings from the National Cardiogenic Shock Initiative Study1,2,3

  • Identify and support cardiogenic shock early
  • Turn down titriation of inotropes aggressively
  • Identify inadequate left ventricular (LV) support and escalate, if CPO <0.6
  • Identify right ventricular (RV) dysfunction early and support
  • Systematically use right heart catheter (RHC) to guide therapy

Clinical Evidence of Impella® Systems: Pathway to Class I Recommendation

Clinical evidence of Impella systems has established safety and effectiveness and validated best practices.

The Procedure

Learn more about femoral access, explant techniques and other best practises.

References

  1. Tehrani, B.N., et al. (2019). JACC. 73, 1659-1669.
  2. Basir, M.B., et al. (2019). Catheter Cardiovasc Interv, 93(7), 1173-1183.
  3. O’Neill, W.W., TCT 2020.

NPS-2632